What is a suitable sliding scale insulin regimen for an insulin-dependent diabetic patient with impaired renal function on peritoneal dialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sliding Scale Insulin Regimen for an Elderly Insulin-Dependent Diabetic on Peritoneal Dialysis

For a 78-year-old, 103.2 kg insulin-dependent diabetic patient on peritoneal dialysis, the recommended sliding scale regimen should include a simplified approach with pre-meal blood glucose targets of 90-150 mg/dL and a conservative correction scale of 2 units rapid-acting insulin for blood glucose >250 mg/dL and 4 units for >350 mg/dL. 1

Baseline Insulin Considerations

Basal Insulin

  • Administer basal insulin in the morning rather than at bedtime to improve monitoring
  • Calculate initial basal dose conservatively due to renal impairment:
    • Reduce total daily insulin dose by approximately 35-40% compared to patients with normal renal function 1
    • For a patient on peritoneal dialysis, start with approximately 0.3 units/kg/day of basal insulin

Prandial Insulin

  • Use a simplified approach for prandial coverage
  • If currently on prandial insulin >10 units/dose: decrease by 50% and consider adding a non-insulin agent if appropriate 1
  • If on prandial insulin ≤10 units/dose: consider discontinuing and using only correction insulin

Recommended Sliding Scale Regimen

Pre-meal Correction Scale:

  • Blood glucose 150-250 mg/dL: No additional insulin
  • Blood glucose >250 mg/dL: Add 2 units rapid-acting insulin
  • Blood glucose >350 mg/dL: Add 4 units rapid-acting insulin 1

Monitoring Requirements:

  • Check blood glucose before each meal and at bedtime
  • Target range: 90-150 mg/dL before meals 1
  • Adjust sliding scale every 2 weeks based on patterns

Special Considerations for Peritoneal Dialysis

  1. Dialysate Glucose Absorption:

    • Peritoneal dialysis solutions contain glucose which can be absorbed systemically
    • Be cautious with icodextrin-containing solutions as they can interfere with certain glucose meters 1
    • Use GDH-NAD or GDH-FAD based glucose meters rather than GDH-PQQ or GO meters
  2. Protein Requirements:

    • Patients on peritoneal dialysis should consume 1.0-1.2 g protein/kg/day 1
    • This higher protein requirement may affect carbohydrate intake and insulin needs
  3. Hypoglycemia Risk:

    • Increased risk due to decreased renal gluconeogenesis and altered insulin clearance 2
    • Ensure patient has hypoglycemia awareness and treatment supplies

Adjustment Algorithm

  1. Weekly Assessment:

    • If >50% of fasting glucose readings are above target: Increase basal insulin by 2 units
    • If >2 fasting glucose readings/week are <80 mg/dL: Decrease basal insulin by 2 units 1
  2. Biweekly Assessment:

    • Review pre-meal glucose patterns every 2 weeks
    • If >50% of pre-meal readings are above target: Increase correction scale doses
    • If experiencing any hypoglycemia (<70 mg/dL): Decrease correction scale doses

Important Precautions

  • Avoid rapid-acting or short-acting insulin at bedtime due to increased risk of nocturnal hypoglycemia 1
  • Discontinue sliding scale when not needed daily
  • Monitor for signs of fluid overload which may require insulin dose adjustments
  • Consider the impact of peritoneal glucose absorption on blood glucose levels
  • Use the shortest available needle length (4-mm pen or 6-mm syringe) to avoid intramuscular injection 3

This regimen prioritizes safety while providing adequate glycemic control, recognizing the increased vulnerability of elderly patients with renal failure to hypoglycemia and its potentially serious consequences.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

EADSG Guidelines: Insulin Therapy in Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.